4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-24-088813
See remarks sold 42,359 shares at an average $8.34 ($353,071)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rahmer Peter See remarks | 2024-07-29 | Sale 10b5-1 | −1,359 | $8.85 | $12,027 | 432,929 | D: show line 1 in the form |
| Rahmer Peter See remarks | 2024-07-29 | Sale 10b5-1 | −12,164 | $8.51 | $103,516 | 420,765 | D: show line 2 in the form |
| Rahmer Peter See remarks | 2024-07-30 | Sale 10b5-1 | −15,128 | $8.28 | $125,260 | 405,637 | D: show line 3 in the form |
| Rahmer Peter See remarks | 2024-07-31 | Sale 10b5-1 | −13,708 | $8.19 | $112,269 | 391,929 | D: show line 4 in the form |
| Open-market sales · 42,359 sh · avg $8.34 · $353,071 | |||||||
Loading xslF345X05/ownership.xml…